We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
Cap. Flow
-$411M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$108M
2
MSFT icon
Microsoft
MSFT
+$73.2M
3
AMZN icon
Amazon
AMZN
+$49.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.8M
5
META icon
Meta Platforms (Facebook)
META
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Financials 13.46%
3 Healthcare 13.26%
4 Consumer Discretionary 12.31%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AHCO icon
2151
AdaptHealth
AHCO
$759M
$957K ﹤0.01%
25,482
+2,942
+13% +$91K
VVX icon
2152
V2X
VVX
$2.65B
$957K ﹤0.01%
19,255
+1,975
+11% +$88.3K
COLL icon
2153
Collegium Pharmaceutical
COLL
$956M
$955K ﹤0.01%
47,695
-81
-0.2% -$1.58K
CWH icon
2154
Camping World
CWH
$653M
$954K ﹤0.01%
36,611
+2,815
+8% +$82.4K
LESL icon
2155
Leslie's
LESL
$11M
$949K ﹤0.01%
+1,710
New +$769K
FRGI
2156
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$948K ﹤0.01%
83,196
+6,218
+8% +$68.5K
ALXO icon
2157
ALX Oncology
ALXO
$290M
$945K ﹤0.01%
10,964
+2,727
+33% +$164K
REPL icon
2158
Replimune Group
REPL
$1.01B
$944K ﹤0.01%
24,753
+5,389
+28% +$225K
PRVB
2159
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$944K ﹤0.01%
55,754
+4,967
+10% +$74.5K
CTRN icon
2160
Citi Trends
CTRN
$605M
$940K ﹤0.01%
18,922
+1,779
+10% +$60.5K
DDS icon
2161
Dillards
DDS
$9.56B
$936K ﹤0.01%
14,851
+638
+4% +$31.2K
MITK icon
2162
Mitek Systems
MITK
$834M
$936K ﹤0.01%
52,668
+2,691
+5% +$37.2K
CSV icon
2163
Carriage Services
CSV
$569M
$934K ﹤0.01%
29,824
+3,607
+14% +$98.3K
VIE
2164
DELISTED
Viela Bio, Inc. Common Stock
VIE
$933K ﹤0.01%
25,932
+1,893
+8% +$66.3K
NWLI
2165
DELISTED
National Western Life Group, Inc. Class A
NWLI
$927K ﹤0.01%
4,489
+541
+14% +$105K
DHIL
2166
DELISTED
Diamond Hill
DHIL
$924K ﹤0.01%
6,187
+625
+11% +$91.1K
TPC
2167
Tutor Perini Cor
TPC
$5.21B
$924K ﹤0.01%
71,365
+8,828
+14% +$119K
FPRX
2168
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$924K ﹤0.01%
54,312
+9,853
+22% +$123K
SENEA icon
2169
Seneca Foods Class A
SENEA
$1.21B
$921K ﹤0.01%
23,079
+2,232
+11% +$90.3K
ORBC
2170
DELISTED
ORBCOMM, Inc.
ORBC
$921K ﹤0.01%
124,180
+14,158
+13% +$76.4K
CAC icon
2171
Camden National
CAC
$976M
$919K ﹤0.01%
25,697
+2,611
+11% +$89.7K
AMRS
2172
DELISTED
Amyris Inc.
AMRS
$910K ﹤0.01%
147,291
+27,712
+23% +$88.6K
ESPR
2173
DELISTED
Esperion Therapeutics
ESPR
$909K ﹤0.01%
34,947
+948
+3% +$28.4K
SPNS
2174
DELISTED
Sapiens International
SPNS
$909K ﹤0.01%
29,684
+2,120
+8% +$62.1K
CPE
2175
DELISTED
Callon Petroleum Company
CPE
$908K ﹤0.01%
69,017
+6,679
+11% +$57.7K

Similar funds

RhumbLine Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
  • RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
  • RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
  • RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
  • RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
  • RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.